Barclays
ECYT

Barclays’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Barclays’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-31,600
Closed -$190K – 7931
2014
Q2 		$190K Sell
31,600
-2,000
-6% -$22.5K ﹤0.01% 4868
2014
Q1 		$773K Buy
+33,600
New +$487K ﹤0.01% 3515

Other funds holding ECYT

OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
CA
Claro Advisors Boston, Massachusetts $830M AUM 21.8% 1-Year Est. Return

Barclays's ECYT Position: Q4 2018 in Review

Barclays sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 34,406 shares — an estimated $611K sold.

Barclays first reported a position in ECYT in Q2 2013 and held it in 22 quarters. The position peaked at $7.23M in Q1 2014. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

  • Barclays reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Barclays sold 34,406 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $611K.
  • Barclays first reported a position in Endocyte, Inc. Common Stock in Q2 2013 and held it in 22 quarters.
  • Barclays's Endocyte, Inc. Common Stock position peaked at $7.23M in Q1 2014.
  • 2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Barclays's 13F filing for Q4 2018, filed 14 Feb 2019.